Skip to main content

Table 1 Demographic and clinical characteristics of patients on ART, and facility-related indicators in Andhra Pradesh and Telangana (2007-12) and in Rajasthan (2008-13)

From: Survival outcomes for first-line antiretroviral therapy in India’s ART program

 

Andhra Pradesh and Telangana (N = 3,340)a

Rajasthan (N = 3,241)b

Variables

Total (% of N)

Deceased (%)

Total (% of N)

Deceased (%)

Patient level

Year of ART initiationc

  2007-08

365 (10.9)

58 (15.9)

  

  2008-09

458 (13.7)

68 (14.9)

422 (13.0)

72 (17.1)

  2009-10

767 (23.0)

97 (12.7)

651 (20.1)

67 (10.3)

  2010-11

829 (24.8)

124 (15.0)

749 (23.1)

90 (12.0)

  2011-12

919 (27.5)

90 (9.8)

850 (26.2)

85 (10.0)

  2012-13

  

569 (17.6)

79 (13.9)

Sex of patient

  Male

1,724 (51.6)

273 (15.8)

1,860 (57.4)

285 (15.3)

  Female

1,561 (46.7)

159 (10.2)

1,360 (42.0)

108 (7.9)

Age of patients (years)

  16–29

857 (25.7)

98 (11.4)

720 (22.2)

66 (9.2)

  30–49

2,152 (64.4)

287 (13.3)

2,250 (69.4)

278 (12.4)

  = >50

329 (9.9)

52 (15.8)

271 (8.4)

49 (18.1)

CD4 count at ART initiation (cells/mm3)

  < =100

782 (23.4)

168 (21.5)

954 (29.4)

209 (21.9)

  101–250

1,870 (56.0)

226 (12.1)

1,562 (48.2)

150 (9.6)

  >250

659 (19.7)

41 (6.2)

696 (21.5)

31 (4.5)

Co-existing tuberculosis

  No

2,823 (84.5)

336 (11.9)

2,582 (79.7)

276 (10.7)

  Yes

515 (15.4)

101 (19.6)

627 (19.4)

117 (18.7)

Ever use of alcohol

  No

2,739 (82.0)

319 (11.7)

2,709 (83.6)

299 (11.0)

  Yes

599 (17.9)

118 (19.7)

519 (16.0)

94 (18.1)

Baseline ART regimend

  STV based regimen with/without EFV

1,377 (41.2)

215 (15.6)

832 (25.7)

146 (17.6)

  ZDV based regimen with/without EFV

1,542 (46.2)

166 (10.8)

2,131 (65.8)

205 (9.6)

Facility level variables

Cumulative ART patient loade

  Below or equal to state average

1,891 (56.6)

262 (13.9)

1,621 (50.0)

190 (11.7)

  Above state average

1,449 (43.4)

175 (12.1)

1,620 (50.0)

203 (12.5)

Ratio of cumulative ART patients to pre-ART patientsf

  Below or equal to state average

1,998 (59.8)

275 (13.8)

2,433 (75.1)

271 (11.1)

  Above state average

1,342 (40.2)

162 (12.1)

808 (24.9)

122 (15.1)

Percent of cumulative loss to follow-up patients g

  Category 1

1,070 (32.0)

123 (11.5)

1,352 (41.7)

174 (12.9)

  Category 2

1,090 (32.6)

148 (13.4)

1,375 (42.4)

150 (10.9)

  Category 3

1,180 (35.3)

166 (14.1)

514 (15.9)

69 (13.4)

  1. aData missing for Andhra Pradesh and Telangana: year of ART initiation for 2; sex of patients for 55; age of patients for 2; CD4 count at ART initiation for 29; co-existing tuberculosis for 2; ever use of alcohol for 2; baseline ART regimen for 421
  2. bData missing for Rajasthan: sex of patients for 21; CD4 count at ART initiation for 29; co-existing tuberculosis for 32; ever use of alcohol for 13; baseline ART regimen for 278
  3. cFinancial year
  4. dSTV is Stavudine, ZDV is Zidovudine, and EFV is Efavirenz
  5. eAverage for Andhra Pradesh and Telangana is 4844 and 4307 for Rajasthan
  6. fFor Andhra Pradesh and Telangana is 0.59 and 0.70 for Rajasthan
  7. gThe categories for Andhra Pradesh and Telangana are <5.6 %, >5.6–8.4 % and >8.4 %; and <3.1 %, 3.1–6.5 % and >6.5 % for Rajasthan